Tuesday, October 21, 2014 1:13:07 PM
Publish or perish. And if you can't find anything good to publish, it severely hurts your credibility. They would not be continuing with this Lympro study if the number of patients studied to date made a difference.
Finally, using any evaluation method, Lympro Ad v healthy controls has never been in the 90s sen and spec, so I am not holding my breath on better results.
JN is certainly free to report that the company expects better results, but that is not offering a sentient opinion. Do the same thing and expecting better results is not a healthy way to proceed.
The truth is incontrovertible. Malice may attack it, ignorance may deride it, but in the end, there it is.
Winston Churchill
FEATURED Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • Oct 1, 2024 8:30 AM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • Oct 1, 2024 7:00 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM
BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM